Torlak gets permit to produce vaccine against flu

Torlak Institute of Virology and Immunology has announced in a release that after the inspection by the Health Ministry and the World Health Organization, it was given permit to produce a medicine for clinical trials - vaccine against flu, splitted, inactivated.

Torlak has got the Certificate of Compliance of Drug Manufacturing with the Guidelines of Good Manufacturing Practices for the medicine Vaccine Against Flu, splitted, inactivated, intended for clinical trials.

The release reads that this certificate is of exceptional importance for Torlak which expects the vaccine to successfully pass all clinical trials and then be made available to citizens for the purpose of preventing seasonal flu.

Institut Torlak

Ministarstvo zdravlja Republike Srbije

WHO Regional Office for Europe

World Health Organization

vaccine against flu

clinical trials

seasonal flu